Cargando…
Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma
BACKGROUND: Immunotherapy is a revolutionary strategy in cancer therapy, but the resistance of which is one of the important challenges. Detecting the regulation of immune cells and biomarkers concerning immune checkpoint blockade (ICB) therapy is of great significance. METHODS: Here, we firstly con...
Autores principales: | Wang, Jingwen, Li, Feng, Xu, Yanjun, Zheng, Xuan, Zhang, Chunlong, Hu, Congxue, Xu, Yingqi, Mi, Wanqi, Li, Xia, Zhang, Yunpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265039/ https://www.ncbi.nlm.nih.gov/pubmed/34238310 http://dx.doi.org/10.1186/s12967-021-02962-8 |
Ejemplares similares
-
Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2022) -
Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets
por: Hu, Congxue, et al.
Publicado: (2022) -
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019) -
Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients
por: Xu, Yingqi, et al.
Publicado: (2019) -
Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma
por: Zhang, Chunlong, et al.
Publicado: (2022)